News
Cheaper alternatives to Ozempic and Wegovy may disappear as FDA reconsiders compounded drug loophole
SHREVEPORT, La. - Many people are using cheaper versions of popular weight-loss shots like Ozempic and Wegovy.
As the FDA’s ban on mass compounding of semaglutide takes effect, Novo Nordisk introduces discounted pricing and new patient ...
Bariatric surgery for severe obesity including gastric banding is under threat as rocketing indemnity insurance premiums and growing malpractice claims drive surgeons out of the field, experts warn.
Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...
Microdosing isn’t just popular for psychedelics. Some consumers are taking smaller than standard doses of GLP-1s—the popular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results